aMoon Fund

New York, New York
cb
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Founded:2016
Firm Location:New York, New York • Boston, Massachusetts • Tel Aviv, Israel • Israel • Ra'anana, Israel
Investor Firms That Co-Invest with aMoon Fund
Maverick CapitalF-Prime Capital PartnersViola VenturesKhosla VenturesLightspeed Venture PartnersVivo CapitalNorthpond VenturesEcho Health Ventures10DHighbury GroupSection 32.406 VenturesPolaris Partners
aMoon Fund Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
Photo of Avital Adler, Analyst at aMoon Fund
Avital Adler
aMoon Fund
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+25
Photo of Tomer Berkovitz, General Partner at aMoon Fund
Tomer Berkovitz
aMoon Fund
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+25
Photo of Isaac Devash, General Partner at aMoon Fund
Isaac Devash
aMoon Fund
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+25
Photo of Tamar Farfel-Becker, Analyst at aMoon Fund
Tamar Farfel-Becker
aMoon Fund
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Seed), Investors in Israel (Other Lists), Investors in Health IT (Series A), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+21
Photo of Osnat Hakimi, Associate at aMoon Fund
Osnat Hakimi
aMoon Fund
n/a
$1.5M
($1M - $2.0M)
Investors in Israel
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Seed), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+25
Photo of Uri Kedem, Analyst at aMoon Fund
Uri Kedem
aMoon Fund
n/a
$1.5M
($1M - $5.0M)
Investors in Israel
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in Health IT (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+25
Photo of Jonathan Lubash, Analyst at aMoon Fund
Jonathan Lubash
aMoon Fund
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Seed), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+26
Photo of Gur Roshwalb, Partner at aMoon Fund
Gur Roshwalb
aMoon Fund
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+25
Photo of Yair Schindel, Managing Partner at aMoon Fund
Yair Schindel
aMoon Fund
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+17
Photo of Reut Shema, Managing Director at aMoon Fund
Reut Shema
aMoon Fund
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Israel (Other Lists), Investors in BioTech (Seed), Investors in Consumer Internet (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Consumer Internet (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Internet (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Consumer Internet (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+21
Photo of Todd Sone, General Partner at aMoon Fund
Todd Sone
aMoon Fund
n/a
$1.5M
($100K - $5.0M)
Investors in Israel
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Israel (Other Lists), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+25